Abstract:Cancer remains a significant global public health concern, with increasing incidence and mortality rates worldwide. Oxidative stress, characterized by the production of reactive oxygen species (ROS) within cells, plays a critical role in the development of cancer by affecting genomic stability and signaling pathways within the cellular microenvironment. Elevated levels of ROS disrupt cellular homeostasis and contribute to the loss of normal cellular functions, which are associated with the initiation and progression of various types of cancer. In this review, we have focused on elucidating the downstream signaling pathways that are influenced by oxidative stress and contribute to carcinogenesis. These pathways include p53, Keap1-NRF2, RB1, p21, APC, tumor suppressor genes, and cell type transitions. Dysregulation of these pathways can lead to uncontrolled cell growth, impaired DNA repair mechanisms, and evasion of cell death, all of which are hallmark features of cancer development. Therapeutic strategies aimed at targeting oxidative stress have emerged as a critical area of investigation for molecular biologists. The objective is to limit the response time of various types of cancer, including liver, breast, prostate, ovarian, and lung cancers. By modulating the redox balance and restoring cellular homeostasis, it may be possible to mitigate the damaging effects of oxidative stress and enhance the efficacy of cancer treatments. The development of targeted therapies and interventions that specifically address the impact of oxidative stress on cancer initiation and progression holds great promise in improving patient outcomes. These approaches may include antioxidant-based treatments, redox-modulating agents, and interventions that restore normal cellular function and signaling pathways affected by oxidative stress. In summary, understanding the role of oxidative stress in carcinogenesis and targeting this process through therapeutic interventions are of utmost importance in combating various types of cancer. Further research is needed to unravel the complex mechanisms underlying oxidative stress-related pathways and to develop effective strategies that can be translated into clinical applications for the management and treatment of cancer.

Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer

Redox regulation of microRNAs in cancer.

MicroRNA Networks Modulate Oxidative Stress in Cancer

MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis

Circular RNAs: Novel Players in the Oxidative Stress-Mediated Pathologies, Biomarkers, and Therapeutic Targets

The crosstalk between non-coding RNAs and oxidative stress in cancer progression

Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications

MicroRNAs: new Players in Cancer Prevention Targeting Nrf2, Oxidative Stress and Inflammatory Pathways

The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role

Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAs

Interaction of Exosomal MicroRNA and Oxidative Stress in the Pathogenesis of Colitis-Associated Cancer

The Role of Oxidative Stress in Tumorigenesis and Progression

Interplay of oxidative stress, cellular communication and signaling pathways in cancer

Oxidative Stress and Cancer Development: Are Noncoding RNAs the Missing Links?

microRNAs, oxidative stress, and genotoxicity as the main inducers in the pathobiology of cancer development

Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?

Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer

Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-Regulated Redox Pathway and its Mechanism

The double-edged roles of ROS in cancer prevention and therapy

MicroRNAs Serve As a Bridge Between Oxidative Stress and Gastric Cancer (Review).

miRNAs Involvement in Modulating Signalling Pathways Involved in Ros-Mediated Oxidative Stress in Melanoma